Direct Meds Tirzepatide Review: Prices, Supply and Cancellation

Direct Meds lists compounded injectable tirzepatide at $399 per month, with evaluation, injection supplies, shipping and nursing support. A separate sublingual tirzepatide offer lists $299 monthly. The lower figure buys a different formulation; it does not establish comparable absorption or clinical results.^1,2

The important choices are the preparation, the supply shipped, the payments attached to it and the deadline for stopping the next order. The September 2025 FDA marketing warning also belongs in this comparison.

Compare the preparation and supplied quantity

The pricing page calls the injectable offer all-inclusive, without a separate membership or access fee. Its broad $147 starting headline is not the named tirzepatide injection price. Confirm your prescribed dose, vial quantity and days supplied alongside the actual payment amount.¹

Our ARSYNL Rx review examines another compounded injection plan: its named page lists $269 monthly, with medication, consultation, supplies and free delivery and no separate membership fee. Its labeling alternates between B6 and B12. Compare prescribed ingredients and supplied quantity alongside the monthly bill, rather than assuming different preparations are equivalent.¹¹

A separate injectable-tirzepatide support page shows $497 per bottle and a three-bottle starter shipment payable in three $497 installments, but its body heading says semaglutide and warns that discounts can differ. That internally inconsistent page is not a verified replacement for the named $399 public offer; confirm which price and supply your order uses.¹⁰

The sublingual product labels its option a 90-day supply shipped together and billed monthly. Its dedicated support article instead describes a 30-day bottle at $299 regardless of dose, including review, prescription, dosing supplies and customer-service support.^2,3

Obtain the bottle count, supply duration, number of charges and remaining balance for the selected order. One $299 payment should not be interpreted as purchasing the entire advertised 90-day shipment. Nor does cancel-anytime marketing explain whether stopping refills removes payments for medicine already supplied.

Support separately explains that certain injectable tirzepatide starter programs ship multiple weeks together while dividing the cost into equal monthly installments. This describes some programs, rather than a universal shipment schedule. The order confirmation should identify which arrangement you are buying.⁵

The sublingual page also mixes a once-weekly benefit statement with a daily-drops administration answer. Obtain prescription-specific instructions instead of using that mixed page as a dosing guide.²

The oral tirzepatide guide explains the formulation distinction. Ask your clinician about evidence for the proposed preparation and approved alternatives; a product page does not demonstrate therapeutic equivalence.

Review, payment and ongoing contact

The product’s publicly indexed signup FAQ describes paying for the first month before completing the clinical intake, with a full refund if the prescription is not approved. This is a denial-specific promise, not a general results guarantee or an unconditional right to return a delivered prescription.²

The process page describes assessment review without an appointment, ongoing nursing access and portal messaging, with email and telephone support during business hours. Ask which clinician handles symptoms, adjustments and follow-up, and whether a live consultation is appropriate. Administrative support and prescribing access serve different purposes.⁸

Published review and shipping times are service claims, not independently measured performance. Confirm when processing starts, when a package is expected and how to report a temperature or delivery problem. A new card charge does not necessarily mean a new shipment is due.

Cancellation has more than one deadline

The April 2026 Terms describe automatic charges every 30 days, with notice five to seven days beforehand. Turn off auto-refill at least 48 hours before processing. An initial cancellation is only an attempt within 24 hours, conditional on the provider network not yet receiving the order; later cancellation is generally unavailable.⁷

Terms exclude refunds for medication already received, while listing exceptions for incorrect, damaged, unsafe or unshipped products and medication denied by a Direct Meds doctor. Report receipt problems within 48 hours; returned prescriptions incur a $35 disposal fee. The footer Refund Policy link leads to these same Terms.⁷

Keep written confirmation of which order was stopped and whether any balance remains. The pricing page’s no-minimum-commitment statement and the product FAQ’s satisfaction promise do not independently settle obligations for a longer shipment already delivered or guarantee a refund for disappointing results.^1,2,5

Published people and pharmacy information

Direct Meds describes itself in its Terms as a platform connecting patients to separate medical providers and pharmacies, rather than the treating practice. Its team page names Dr. Justin Hohl as Chief Medical Officer. That is a company-reported role, not verification of your assigned prescriber or credentials.^7,9

The sublingual product FAQ names CraftedRx and ChemistryRx, with state-based routing. Obtain confirmation of the actual dispenser for your preparation and location; a list of possible pharmacies does not establish the facility supplying a particular order. Check the label, concentration, storage instructions and beyond-use date.²

Do not treat the page’s pharmacy-registration, certification or product-approval language as independent verification of a compounded medicine. Availability also needs confirmation for your location; the product FAQ’s state restrictions should not be repeated as universal legal prohibitions.

FDA warning and evidence limits

FDA’s September 9, 2025 warning letter to directmeds.com, Inc. dba DirectMeds, MARCS-CMS 716822, addressed misleading compounded semaglutide and tirzepatide marketing, including implications of sameness with approved drugs. It does not establish a current closure, recall or closeout; no resolution is established here.⁴

Compounded products are not FDA-approved finished medicines. FDA guidance describes concerns about unapproved GLP-1 products; approved-injection research cannot independently verify a Direct Meds vial or sublingual preparation.⁶

Our assessment

Direct Meds publishes separate injection and sublingual prices and meaningful cancellation rules. The unresolved comparison is the selected formulation, shipment and payment obligation, especially where monthly billing accompanies a longer supply. Clear written order details matter more than a general cancel-anytime slogan.

Compare other provider programs, approved Zepbound costs and the compounded-treatment guide using the actual preparation and agreement, with clinical guidance suited to your circumstances.